$0.7578
-0.07-8.37%
At close: -
$0.7600
0.002200.29%
After Hours: 4:06 PM EDT
Comments
Loading...
Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock, Earnings Estimates, EPS, And Revenue
Lexicon Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 10
EPS Estimate
$-0.160
Quarterly Revenue Estimate
$8.41 M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$5.23 M
Analyze the earnings history of Lexicon Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Lexicon Pharmaceuticals (LXRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-12 | $-0.18 | $-0.16 | -12.5 % |
| Jun 2024 | 2024-08-01 | $-0.17 | $-0.19 | 10.5 % |
| Dec 2023 | 2024-03-11 | $-0.20 | $-0.22 | 9.09 % |
| Sep 2023 | 2023-11-08 | $-0.21 | $-0.21 | 0.00 % |
Lexicon Pharmaceuticals (LXRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-12 | $1.75M | $2.93M | -40.3 % |
| Jun 2024 | 2024-08-01 | $1.65M | $2.83M | -41.8 % |
| Mar 2024 | 2024-05-02 | $1.13M | $1.37M | -17.5 % |
| Dec 2023 | 2024-03-11 | $702.00K | $1.24M | -43.4 % |
FAQ
When is Lexicon Pharmaceuticals (NASDAQ:LXRX) reporting earnings?
Lexicon Pharmaceuticals (LXRX) is scheduled to report earnings on March 10, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
What were the latest earnings per share (EPS) for Lexicon Pharmaceuticals (NASDAQ:LXRX)?
The Actual EPS was $-0.18, which missed the estimate of $-0.16.
What were Lexicon Pharmaceuticals’s (NASDAQ:LXRX) revenues?
The Actual Revenue was $1.8M, which missed the estimate of $2.9M.
Browse earnings estimates, EPS, and revenue on all stocks.